Literature DB >> 6526922

High-performance liquid chromatographic determination of a new anti-inflammatory agent, nabumetone, and its major metabolite in plasma using fluorimetric detection.

J E Ray, R O Day.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6526922     DOI： 10.1016/s0378-4347(00)85146-4

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  2 in total

Review 1.  Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1997-12       Impact factor: 6.447

Review 2.  Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.

Authors:  H A Friedel; P A Todd
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.